A Healthy Index – The Standard and Poors ASX 200 Health Index.
This index of 18 leading Healthcare stocks escaped the 2008 GFC downturn and in 2012 resumed its uptrend to more than double; from about 7,500 to resistance at 19,950.
In the last 12 months, the index rise lost momentum, and entered a trading range, but the primary trend is still up. Break-out above 20,000 might signify resumption of the uptrend.
Some of the best performing stocks in the ASX are in this index. At present it is composed of:
- Ansell Ltd – ANN
- Cochlear Ltd – COH
- CSL Ltd – CSL
- Estia Health Ltd – EHE
- Fisher and Paykel Healthcare – FPH
- Greencross Ltd Ltd – GXL
- Healthscope Ltd – HSO
- Japara Healthcare Ltd – JHC
- Mayne Pharma Group – MYX
- Mesoblast – MSB
- Primary Health Care – PRY
- Ramsay Health Care – RHC
- Regis Healthcare Ltd – REG
- ResMed Inc – RMD
- Sigma Pharmaceuticals Ltd
- Sirtex Medical Ltd. – SRX
- Sonic Healthcare – SHL
- Virtus Health Ltd – VRT.
Categories: Chart Review
Leave a Reply